Implementing multifactorial psychotherapy research in online virtual environments (IMPROVE-2): study protocol for a phase III trial of the MOST randomized component selection method for internet cognitive-behavioural therapy for depression

Edward Watkins, Alexandra Newbold, Michelle Tester-Jones, Mahmood Javaid, Jennifer Cadman, Linda M Collins, John Graham, Mohammod Mostazir, Edward Watkins, Alexandra Newbold, Michelle Tester-Jones, Mahmood Javaid, Jennifer Cadman, Linda M Collins, John Graham, Mohammod Mostazir

Abstract

Background: Depression is a global health challenge. Although there are effective psychological and pharmaceutical interventions, our best treatments achieve remission rates less than 1/3 and limited sustained recovery. Underpinning this efficacy gap is limited understanding of how complex psychological interventions for depression work. Recent reviews have argued that the active ingredients of therapy need to be identified so that therapy can be made briefer, more potent, and to improve scalability. This in turn requires the use of rigorous study designs that test the presence or absence of individual therapeutic elements, rather than standard comparative randomised controlled trials. One such approach is the Multiphase Optimization Strategy, which uses efficient experimentation such as factorial designs to identify active factors in complex interventions. This approach has been successfully applied to behavioural health but not yet to mental health interventions.

Methods/design: A Phase III randomised, single-blind balanced fractional factorial trial, based in England and conducted on the internet, randomized at the level of the patient, will investigate the active ingredients of internet cognitive-behavioural therapy (CBT) for depression. Adults with depression (operationalized as PHQ-9 score ≥ 10), recruited directly from the internet and from an UK National Health Service Improving Access to Psychological Therapies service, will be randomized across seven experimental factors, each reflecting the presence versus absence of specific treatment components (activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, absorption, self-compassion training) using a 32-condition balanced fractional factorial design (2IV7-2). The primary outcome is symptoms of depression (PHQ-9) at 12 weeks. Secondary outcomes include symptoms of anxiety and process measures related to hypothesized mechanisms.

Discussion: Better understanding of the active ingredients of efficacious therapies, such as CBT, is necessary in order to improve and further disseminate these interventions. This study is the first application of a component selection experiment to psychological interventions in depression and will enable us to determine the main effect of each treatment component and its relative efficacy, and cast light on underlying mechanisms, so that we can systematically enhance internet CBT.

Trial registration: Current Controlled Trials ISRCTN24117387 . Registered 26 August 2014.

Keywords: Cognitive behavioural therapy; Depression; Factorial; MOST; Online.

Figures

Fig. 1
Fig. 1
Consort Flow Diagram for IMPROVE-2 study showing recruitment flow

References

    1. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS. Grand challenges in global mental health. Nature. 2011;475:27–30. doi: 10.1038/475027a.
    1. WHO . The Global Burden of Disease 2004 Update. Switzerland: WHO Press; 2008.
    1. Judd LL. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry. 1997;5:989–991. doi: 10.1001/archpsyc.1997.01830230015002.
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;36:1747–1757. doi: 10.1016/S0140-6736(06)68770-9.
    1. Hollon SD, Munoz RF, Barlow DH, Beardslee WR, Bell CC, Guillermo BB, Gregory NC, Franciosi LP, Kazdin AE, Kohn L, Linehan MM, Markowitz JC, Persons JB, Niederehe G, Somers D. Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access. Biol Psychiatry. 2002;52:610–630. doi: 10.1016/S0006-3223(02)01384-7.
    1. Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect Psych Sci. 2011;6:21–37. doi: 10.1177/1745691610393527.
    1. Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One. 2010;5:e13196. doi: 10.1371/journal.pone.0013196.
    1. Leykin Y, Muñoz RF, Contreras O. Are consumers of Internet health information “cyberchondriacs”? Characteristics of 24,965 users of a depression screening site. Depress Anxiety. 2012;29:71–77. doi: 10.1002/da.20848.
    1. Barlow DH. Psychological treatments. American Psychologist. 2004;59(9):869–78. doi: 10.1037/0003-066X.59.9.869.
    1. Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Ann Rev Clin Psych. 2007;3:1–27. doi: 10.1146/annurev.clinpsy.3.022806.091432.
    1. Holmes EA, Craske MG, Graybiel AM. Psychological treatments: a call for mental health science. Nature. 2014;511:287–289. doi: 10.1038/511287a.
    1. IOM (Institute of Medicine) Psychosocial interventions for mental and substance use disorders: A framework for establishing evidence-based standards. Washington: The National Academies Press; 2015.
    1. Collins LM, Baker TB, Piper ME, Jorenby DE, Smith SS, Christiansen BA, Schlam TR, Cook JW, Fiore MC. The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med. 2010;41:208–226. doi: 10.1007/s12160-010-9253-x.
    1. Collins LM, Dziak JD, Kugler KC, Trail JB. Factorial experiments: Efficient tools for evaluation of intervention components. Am J Prev Med. 2014;47:498–504. doi: 10.1016/j.amepre.2014.06.021.
    1. Collins LM, Dziak JD, Li R. Design of experiments with multiple independent variables: A resource management perspective on complete and reduced factorial designs. Psych Methods. 2009;14:202–224. doi: 10.1037/a0015826.
    1. Collins LM, Kugler KC, Gwadz MV. Optimization of multicomponent behavioral and biobehavioral interventions for the prevention and treatment of HIV/AIDS. AIDS Behav. 2015;20:197–214. doi: 10.1007/s10461-015-1145-4.
    1. Collins LM, Murphy SA, Nair VN, Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005;30:65–73. doi: 10.1207/s15324796abm3001_8.
    1. Collins LM, Murphy SA, Strecher V. The Multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART) Am J Prev Med. 2007;32:S112–S118. doi: 10.1016/j.amepre.2007.01.022.
    1. Collins LM, Nahum-Shani I, Almirall D. Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART) Clin Trials. 2014;11:426–434. doi: 10.1177/1740774514536795.
    1. Wu CJ, Hamada MS. Experiments: planning, analysis, and optimization. 3. New York: John Wiley & Sons; 2011.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Br Med J. 2008;337:a1655. doi: 10.1136/bmj.a1655.
    1. McClure JB, Derry H, Riggs KR, Westbrook EW, St. John J, Shortreed SM, Bogart A, An LC. Questions about quitting (Q2): Design and methods of a Multiphase Optimization Strategy (MOST) randomized screening experiment for an online, motivational smoking cessation intervention. Contemp Clin Trials. 2012;33:1094–1102. doi: 10.1016/j.cct.2012.06.009.
    1. Strecher VJ, McClure JB, Alexander G, Chakraburty B, Nair V, Konkel J, et al. Web-based smoking cessation programs: results of a randomized trial. Am J Prev Med. 2008;34:373–81. doi: 10.1016/j.amepre.2007.12.024.
    1. Schlam TR, Fiore MC, Smith SS, Fraser S, Bolt DM, Collins LM, Mermelstein R, Piper ME, Cook JW, Jorenby DE, Loh WY, Baker TB. Comparative effectiveness of intervention components for producing long-term abstinence from smoking: A factorial screening experiment. Addiction. 2016;111:142–155. doi: 10.1111/add.13153.
    1. Piper ME, Fiore MC, Smith SS, Fraser D, Bolt DM, Collins LM, Mermelstein R, Schlam TR, Cook JW, Jorenby DE, Loh WY, Baker TB. Identifying effective intervention components for smoking cessation: A factorial screening experiment. Addiction. 2016;111:129–141. doi: 10.1111/add.13162.
    1. Medical Research Council (2008) Accessed 11 Dec 2012
    1. Collins LM, Chakraborty B, Murphy SA, Strecher V. Comparison of a phased experimental approach and a single randomized clinical trial for developing multicomponent behavioral interventions. Clin Trials. 2009;6:5–15. doi: 10.1177/1740774508100973.
    1. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford Press; 1979.
    1. Watkins ER, Mullan E, Wingrove J, Rimes K, Steiner H, Bathurst N, Eastman R, Scott J. Rumination-focused cognitive-behavioural therapy for residual depression: phase II randomised controlled trial. Br J Psychiatry. 2011;199:1–6. doi: 10.1192/bjp.bp.110.090282.
    1. Watkins ER, Taylor RS, Byng R, Baeyens C, Read R, Pearson K, Watson L. Guided self-help concreteness training as an intervention for major depression in primary care: a Phase II randomized controlled trial. Psychol Med. 2012;42:1359–1371. doi: 10.1017/S0033291711002480.
    1. Ferster CB. A functional analysis of depression. Am Psychol. 1973; 28(10): 857-870
    1. Watkins ER, Nolen-Hoeksema S. A habit-goal framework of depressive rumination. J Abnorm Psychol. 2014;123:24–34. doi: 10.1037/a0035540.
    1. Watkins ER. Depressive rumination: Investigating mechanisms to improve cognitive-behavioral treatments. Cogn Behav Ther. 2009;38:8–14. doi: 10.1080/16506070902980695.
    1. Gilbert P. Introducing compassion focused therapy. Advances Psychiatric Treat. 2009;15:199–208. doi: 10.1192/apt.bp.107.005264.
    1. Gilbert P. Compassion-focused Therapy: Distinctive Features. London: Routledge; 2010.
    1. Leary MR, Tate EB, Adams CE, Allen AB, Hancock J. Self-compassion and reactions to unpleasant self-relevant events: the implications of treating oneself kindly. J Pers Soc Psychol. 2007;92(5):887–904. doi: 10.1037/0022-3514.92.5.887.
    1. Baskin TW, Tierney SC, Minami T, Wampold BE. Establishing specificity in psychotherapy: A meta-analysis of structural equivalence of placebo controls. J Cons Clin Psychol. 2003;71:973–979. doi: 10.1037/0022-006X.71.6.973.
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Bebbington PE, Nyani T. The Psychosis Screening Questionnaire. Internat J Meth Psychiatric Res. 1995;5:11–19.
    1. First MB, Spitzer RL MG, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN) New York: Biometrics Research, New York State Psychiatric Institute; 2002.
    1. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28:487–495. doi: 10.1016/0005-7967(90)90135-6.
    1. Treynor W, Gonzalez R, Nolen-Hoeksema S. Rumination reconsidered: A psychometric analysis. Cognitive Therapy Research. 2003;27:247–259. doi: 10.1023/A:1023910315561.
    1. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166:1092–1097. doi: 10.1001/archinte.166.10.1092.
    1. Muthen BO, Curran PJ. General longitudinal modeling of individual differences in experimental designs: a latent variable framework for analysis and power estimation. Psych Methods. 1997;2:371–402. doi: 10.1037/1082-989X.2.4.371.
    1. Jacobson NS, Martell CR, Dimidjian S. Behavioral Activation for depression: Returning to contextual roots. Clinical Psych Science Practice. 2001;8:255–270. doi: 10.1093/clipsy.8.3.255.
    1. Martell CR, Addis ME, Jacobson NS. Depression in context: Strategies for guided action. New York: Norton; 2001.
    1. Watkins ER. Rumination-focused Cognitive Behavioural Therapy for Depression. New York: Guilford Press; 2016.
    1. Watkins ER. Constructive and Unconstructive Repetitive Thought. Psychol Bulletin. 2008;134:163–206. doi: 10.1037/0033-2909.134.2.163.
    1. Watkins ER, Moberly NJ, Moulds ML. Processing mode causally influences emotional reactivity: Distinct effects of abstract versus concrete construal on emotional response. Emotion. 2008;8:364–378. doi: 10.1037/1528-3542.8.3.364.
    1. Csikszentmihalyi M. Flow: The classic work on how to achieve happiness. London: Rider; 2002.
    1. Kuyken W, Watkins ER, Holden E, White K, Taylor RS, Byford S, Evans A, Radford S, Teasdale JD, Dalgleish T. How does Mindfulness-based Cognitive Therapy work? Behav Res Ther. 2010;48:1105–1112. doi: 10.1016/j.brat.2010.08.003.
    1. Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: A simple measure of Impairment in functioning. Br J Psychiatry. 2002;180:461–464. doi: 10.1192/bjp.180.5.461.
    1. Gardner B, Abraham C, Lally P, de Bruijn G. Towards parsimony in habit measurement: Testing the convergent and predictive validity of an automaticity subscale of the Self-Report Habit Index. Int J Behav Nutr Phys Act. 2012;9(1):102. doi: 10.1186/1479-5868-9-102.
    1. Carver CS. Generalization, adverse events, and development of depressive symptoms. J Person. 1998;66:609–620. doi: 10.1111/1467-6494.00026.
    1. Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychotherapy. 2011;18:250–255. doi: 10.1002/cpp.702.
    1. Hollon SD, Kendall PC. Cognitive self-statements in depression: development of an automatic thoughts questionnaire. Cognitive Ther Res. 1980;4:383–395. doi: 10.1007/BF01178214.
    1. Manos RC, Kanter JW, Luo W. The Behavioral Activation for Depression Scale–Short Form: Development and Validation. Behav Therapy. 2011;42:726–739. doi: 10.1016/j.beth.2011.04.004.
    1. Engeser S, Rheinberg F. Flow, performance and moderators of challenge-skill balance. Motiv Emot. 2008;32:158–172. doi: 10.1007/s11031-008-9102-4.
    1. Tabachnick BG, Fidell LS. Using multivariate statistics. 4. Needham Heights, MA: Allyn & Bacon; 2001.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi: 10.1186/1741-7015-8-18.
    1. Angrist JD, Imbens GW, Rubin DB. Identification of Causal Effects Using Instrumental Variables. J Am Stat Assoc. 1996;91:444–455. doi: 10.1080/01621459.1996.10476902.
    1. Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res. 2005;14:369–395. doi: 10.1191/0962280205sm403oa.
    1. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59:877–883. doi: 10.1001/archpsyc.59.10.877.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj